AMPLATZER™ Cardiac Plug Observational Post-Approval Study

CompletedOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

November 14, 2016

Primary Completion Date

January 29, 2021

Study Completion Date

January 29, 2021

Conditions
Non-valvular Atrial Fibrillation (NVAF)
Interventions
DEVICE

AMPLATZER™ Cardiac Plug

The AMPLATZER™ Cardiac Plug is a transcatheter, self-expanding device intended for use in preventing thrombus embolization from the left atrial appendage. The device is constructed from a nitinol mesh and consists of a lobe and a disc connected by a central waist. The device is designed to facilitate occlusion. The lobe has stabilizing wires to improve device placement and retention. The device has threaded screw attachments at each end for connection to the delivery and loading cables. The device has radiopaque markers at each end and at the stabilizing wires. Device Sizes: 16, 18, 20, 22, 24, 26, 28, and 30 mm (lobe diameter) Delivery System: AMPLATZER TorqVue® 45º x 45º (sheath sizes 9, 10, or 13 Fr)

Trial Locations (6)

210029

Jiangsu Province Hospital, Nanjing

310006

The First Affiliated Hospital of Zhejiang University, Hangzhou

310016

Sir Run Run Shaw Hospital, Zhejiang

315000

Ningbo First Hospital, Ningbo

430000

Wuhan Asia Heart Hospital, Wuhan

510060

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY